Panelists discuss how simpler treatment regimens with fewer restrictions, such as the new nilotinib formulation without ...

Treatment-related adverse effects were reported in 97.2% of heavily pretreated patients with uterine serous carcinoma taking ...

Panelists discuss how managing common adverse events associated with tyrosine kinase inhibitors (TKIs) such as nilotinib requires proactive strategies including supportive medications, dose ...

The FDA has granted accelerated approval to avutometinib (VS-6766) plus defactinib (VS-6063) for the treatment of adult ...

Use of the 1.5T Elekta Unity MR-Linac was associated with reduced rates of erectile dysfunction at 6, 12, and 18 months in ...

ADRX-0706 has received FDA fast track designation for the treatment of metastatic or locally advanced squamous cell cervical ...

T-DXd followed by THP improved pCR in high-risk, early-stage HER2+ breast cancer in the phase 3 DESTINY-Breast11 trial.

Oncology nurses can enhance endometrial cancer recovery by fostering strong social support networks and improving ...

Infusion bays designed with nurse input provide patients the choice between privacy and community while allowing support from loved ones.

First year of therapy is particularly crucial: Sets trajectory for future treatment outcomes Establishes patterns that predict long-term disease control Determines potential for deeper molecular ...